Genocea Biosciences Inc. (GNCA) Declined -6.32% or -0.04 To Price $0.56 On Monday


Genocea Biosciences Inc. (GNCA) declined -6.32% or -0.04 to $0.56. It is nearly 522737 shares traded, which is 155.34% compare to the average total volume 336503. The market cap of GNCA is $48.53 million. The year to date change is -57.7%. The 52 week price range is from $0.56 to $5.7. Price of GNCA have changed -6.56% during last week. It have changed -5.33% over last month, -37.17% over last 3 months, -48.00% over last 6 months and -88.59% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for GNCA is 0.69. It is 23.21% above current price. The 200-day Moving Averages for GNCA is 0.93. It is 66.07% above current price. The 52-week High is 5.7. It is 917.86% from the current price. The 52-week Low is 0.56. The stock hits 52-week low today.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of GNCA is 3.73 on 2018-08-15. Short % to float is 1.52%. There are some statistics of GNCA. It is has market cap $48.53 million. The share outstanding is 86.63 million. The average volume is 336503. It has 34.26M cash and 30.09M in debt. The percent of top 15 Institution holding is 57.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of GNCA is -296.13%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of GNCA is -104.59%.


Tags:

Share this post